Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular expression of polycystin-2.

Vicente E Torres1,2, Yiquiang Cai3, X I Chen1

  • 1Nephrology Research Unit, Division of Nephrology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota.

Journal of the American Society of Nephrology : JASN
|January 3, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perception, Synaptic Plasticity, and Spiking Neuron Function Enabled by a 2D Ferroelectric NbOBr<sub>2</sub> for Neuromorphic Vision.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Cilia to basement membrane signaling is a biomechanical driver in models of autosomal dominant polycystic kidney disease.

The Journal of clinical investigation·2026
Same author

A non-van der Waals platform for deep-subwavelength twist-polaritonics based on β-Ga<sub>2</sub>O<sub>3</sub> nanoflakes.

Nanoscale horizons·2026
Same author

APOL1-risk alleles modulate T-cell receptor signaling to promote allograft rejection.

The Journal of clinical investigation·2026
Same author

Threading an Aluminum Molecular Ring Onto a Chemically Growing Copper-Directed Polyrotaxane.

Angewandte Chemie (International ed. in English)·2026
Same author

Nanocarrier-empowered aggregation-induced luminescence and its therapeutic promise in oncology.

Nanoscale·2026

Polycystin-2 is expressed in vascular smooth muscle cells, similar to polycystin-1. This suggests polycystic kidney disease gene mutations directly contribute to vascular issues like intracranial aneurysms.

Area of Science:

  • Vascular Biology
  • Genetics
  • Nephrology

Background:

  • Autosomal-dominant polycystic kidney disease (ADPKD) involves genetic defects affecting polycystin-1 (PKD1) and polycystin-2 (PKD2).
  • Vascular manifestations, including intracranial aneurysms, are observed in ADPKD patients, suggesting a direct role of these genetic defects in vascular complications.

Purpose of the Study:

  • To investigate the vascular expression and localization of polycystin-2 (PKD2) in smooth muscle cells.
  • To compare polycystin-2 expression with that of polycystin-1 in the vasculature.
  • To determine the potential role of polycystin-2 in the pathogenesis of vascular abnormalities in ADPKD.

Main Methods:

  • Studied PKD2 mRNA and protein expression in cultured pig aortic VSMC using Northern and Western blotting.

Related Experiment Videos

  • Utilized immunofluorescence and immunohistochemistry to localize polycystin-2 in various vascular tissues and ADPKD-related aneurysms.
  • Employed Pkd2 wild-type and null mice tissues to validate immunostaining specificity.

    • Main Results:

    • Polycystin-2 mRNA and protein were detected in cultured pig aortic VSMC.
    • Immunofluorescence showed cytoplasmic localization of polycystin-2 in VSMC, with its distribution influenced by cytoskeletal agents but not directly associated with the cytoskeleton.
    • Immunohistochemistry revealed polycystin-2 in normal human arteries and intracranial aneurysms, with varying staining intensity.

    Conclusions:

    • The vascular smooth muscle expression of polycystin-2 mirrors that of polycystin-1, supporting their involvement in a shared pathway.
    • These findings suggest that mutations in PKD1 and PKD2 play a direct pathogenic role in the vascular complications associated with ADPKD.